Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001140361-24-043041
Filing Date
2024-10-08
Accepted
2024-10-08 07:15:41
Documents
5

Document Format Files

Seq Description Document Type Size
1 POS AM ef20036385_posam.htm POS AM 66909
2 EXHIBIT 5.1 ef20036385_ex5-1.htm EX-5.1 10312
3 EXHIBIT 23.1 ef20036385_ex23-1.htm EX-23.1 1878
4 EXHIBIT 23.2 ef20036385_ex23-2.htm EX-23.2 2298
5 image0.jpg GRAPHIC 415582
  Complete submission text file 0001140361-24-043041.txt   654942
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-322-1602
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0331
Type: POS AM | Act: 33 | File No.: 333-274899 | Film No.: 241359176
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)